Telexos
Biotechnologieforschung
Weilheim, Bavaria 127 Follower:innen
Analysis of simple blood samples improve significantly personalized cancer diagnostics and therapies.
Info
Telexos developed a new technology which can quantitatively detect and analyze rare cells out of a blood sample (8ml). This makes it possible to detect just one rare cell out of 40 billion blood cells, isolate it as a single cell and characterize this cell in respect to protein and genomic marker (e.g., drug targets, resistance marker). This makes this technology unique. This technology is applicable for circulating tumor cells (CTCs) and rare white blood cells (WBCs) like T(reg) or CART cells. First results (using CTCs) for stratification of breast cancer patients and therapy monitoring of breast cancer patients look quite promising. We now look for partnerships/cooperations.
- Website
-
http://www.telexos.de
Externer Link zu Telexos
- Branche
- Biotechnologieforschung
- Größe
- 2–10 Beschäftigte
- Hauptsitz
- Weilheim, Bavaria
- Art
- Privatunternehmen
- Spezialgebiete
- circulating tumor cells, cancer diagnostics, single cell analysis, therapy monitoring, rare cell, cell separation, oncology, molecular analysis, liquid biopsy und CTC
Orte
-
Primär
Weilheim, Bavaria 82362, DE
-
Am Biopark 11
Regensburg, Bavaria 93053, DE